News of the WeekClinical Trials

Proposed Rules Aim to Curb Financial Conflicts of Interest

See allHide authors and affiliations

Science  11 Jan 2002:
Vol. 295, Issue 5553, pp. 246-247
DOI: 10.1126/science.295.5553.246

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A new policy adopted by the Association of American Medical Colleges urges universities to disqualify investigators from conducting clinical trials if the scientists hold a significant financial interest in companies that could be affected by the results. The guidelines would apply to all human subjects research, not just studies funded by the National Institutes of Health or other federal agencies. Critics argue that the new rules could impede innovation, however, and even supporters worry that implementing them will be expensive.